Recap: bluebird bio Q3 Earnings

Recap: bluebird bio Q3 Earnings

bluebird bio BLUE reported its Q3 earnings results on Monday, November 7, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

bluebird bio beat estimated earnings by 16.07%, reporting an EPS of $-0.94 versus an estimate of $-1.12.

Revenue was down $22.61 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.03 which was followed by a 22.05% increase in the share price the next day.

Here's a look at bluebird bio's past performance:

 

Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate -1.24 -1.39 -1.88 -2.58
EPS Actual -1.27 -1.66 -2.14 -3.16
Revenue Estimate 680K 730K 5.08M 26.06M
Revenue Actual 1.52M 1.95M 1.61M 22.68M

To track all earnings releases for bluebird bio visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarnings